In this study, we investigated the antitumor effects of anti-VEGFR2 antibody inhibition in HCC after anti-PD-L1/anti-VEGF-A treatment and examined the alteration of the TME constructed by CSCs. This evidence concerns the gene CD274 and hepatocellular carcinoma.